Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 392, pseudogene (RNU6-392P) is a non-coding, processed pseudogene derived from the highly conserved small nuclear RNA U6 gene. U6 snRNA itself is an essential, non-coding RNA that forms part of the spliceosome complex and directly catalyzes the excision of introns from pre-mRNA in eukaryotes[2]. Unlike the functional U6 snRNA, pseudogenes like RNU6-392P do not encode active RNA molecules; they arise through retrotransposition events involving Long Interspersed Nuclear Elements (LINEs) or other mobile elements and serve as genomic records of such activity[4]. RNU6-392P has no known physiological role, disease relevance, or druggability. It should not be considered a therapeutic target, and references to this entry as a target may be inaccurate or misleading.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 392, pseudogene (RNU6-392P).